AMBASSADOR: Adjuvant Pembro Boosts DFS in Urothelial Cancer AMBASSADOR: Adjuvant Pembro Boosts DFS in Urothelial Cancer

Interim findings from the ongoing AMBASSADOR trial revealed a significant DFS benefit with adjuvant pembrolizumab but no overall survival benefit at this point.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news